Case Report | Open Access
M. I. Spasova, I. S. Ivanov, J. G. Grudeva-Popova, A. A. Stoyanova, H. K. Dimitrov, I. N. Moumdjiev, "Hodgkin's Disease with Atypical Clinical Presentation, Associated with Ataxia-Telangiectasia", Scholarly Research Exchange, vol. 2009, Article ID 974576, 4 pages, 2009. https://doi.org/10.3814/2009/974576
Hodgkin's Disease with Atypical Clinical Presentation, Associated with Ataxia-Telangiectasia
The authors report a 4-year-old male with Hodgkin's disease with atypical clinical presentation, laboratory data and imaging studies as well as an increased radiosensitivity. These were the first symptoms which raised the suspicion of ataxia-telangiectasia. The lymphoma presented as a solid tumor mass in the right upper posterior mediastinum without peripheral lymphadenopathy. The alpha-fetoprotein was significantly increased and the diagnosis of a germ-cell tumor or neuroblastoma was suspected. After partial resection of the tumor the histology indicated Hodgkin's disease-mixed cellularity. The boy received chemotherapy according to DAL HD-95 protocol without any unusual toxicity. Low-dose radiation therapy of the upper and middle mediastinum was followed by early radiation-induced esophagitis and appearance of a large pericardial effusion one year later. Ataxia and bulbar and skin telangiectasias at the radiation site appeared in the next years. He suffered recurrent pulmonary infections and succumbed to severe pneumonia with respiratory failure and pulmonary hypertension five years after the diagnosis of malignant lymphoma without evidence of recurrence of Hodgkin's disease.
- S. Maricich and H. Zoghbi, “The cerebellum and the hereditary ataxias,” in Pediatric Neurology: Principles and Practice, K. F. Swaimann, S. Ashwal, and D. M. Ferriero, Eds., pp. 1241–1269, Mosby Elsevier, Philadelphia, Pa, USA, 2006.
- F. Hecht and B. K. Hecht, “Cancer in ataxia-telangiectasia patients,” Cancer Genetics and Cytogenetics, vol. 46, no. 1, pp. 9–19, 1990.
- C. Sandoval and M. Swift, “Hodgkin's disease in ataxia-telangiectasia patients with poor outcomes,” Medical and Pediatric Oncology, vol. 40, no. 3, pp. 162–166, 2003.
- R. Bernstein, M. Pinto, and T. Jenkins, “Ataxia telangiectasia with evolution of monosomy 14 and emergence of Hodgkin's disease,” Cancer Genetics and Cytogenetics, vol. 4, no. 1, pp. 31–37, 1981.
- D. C. Strollo, M. L. Rosado-de-Christenson, and J. R. Jett, “Primary mediastinal tumors—part II: tumors of the middle and posterior mediastinum,” Chest, vol. 112, no. 5, pp. 1344–1357, 1997.
- R. C. Murphy, W. E. Berdon, C. Ruzal-Shapiro et al., “Malignancies in pediatric patients with ataxia telangiectasia,” Pediatric Radiology, vol. 29, no. 4, pp. 225–230, 1999.
- B. Yalçin, M. T. Kutluk, Ö. Sanal et al., “Hodgkin's disease and ataxia telangiectasia with pulmonary cavities,” Pediatric Pulmonology, vol. 33, no. 5, pp. 399–403, 2002.
- “Ataxia-telangiectasia,” Online Mendelian Inheritance in Men, September 2008, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=208900.
- A. Stray-Pedersen, A. Borresen-Dale, E. Paus, C. R. Lindman, T. Burgers, and T. G. Abrahamsen, “Alpha fetoprotein is increasing with age in ataxia-telangiectasia,” European Journal of Paediatric Neurology, vol. 11, no. 6, pp. 375–380, 2007.
- H. Irsfeld, D. Körholz, G. Janßen, V. Wahn, and H. Schroten, “Fatal outcome in two girls with Hodgkin's disease complicating ataxia- telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy,” Medical and Pediatric Oncology, vol. 34, no. 1, pp. 62–64, 2000.
- R. Y. J. Tamminga, W. V. Dolsma, J. A. Leeuw, and H. H. Kampinga, “Chemo- and radiosensitivity testing in a patient with ataxia telangiectasia and Hodgkin's disease,” Pediatric Hematology and Oncology, vol. 19, no. 3, pp. 163–171, 2002.
- M. F. Lavin, N. Gueven, S. Bottle, and R. A. Gatti, “Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia,” British Medical Bulletin, vol. 81-82, no. 1, pp. 129–147, 2007.
- D. Körholz, A. Claviez, D. Hasenclever et al., “The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies,” Klinische Pädiatrie, vol. 216, no. 3, pp. 150–156, 2004.
- T. Niehues, G. Schellong, W. Dörffel et al., “Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies,” Klinische Pädiatrie, vol. 215, no. 6, pp. 315–320, 2003.
- F. Pein, L. Iserin, F. de Vathaire, and J. Lemerle, “Cardiac toxicity of cancer treatment regimes in children and adolescents: physiopathology, clinical data and the paediatric oncologist's point of view,” Bulletin du Cancer, vol. 91, pp. S185–S191, 2004.
- Z. Miltényi, L. Gergely, and A. Illés, “Chronic pericarditis in Hodgkin's disease,” Orvosi Hetilap, vol. 143, no. 48, pp. 2687–2689, 2002.
- P. Zinzani, F. Gherlinzoni, G. Piovaccari et al., “Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients,” Hematologica, vol. 81, no. 2, pp. 132–137, 1996.
- C. Sandoval and M. Swift, “Treatment of lymphoid malignancies in patients with ataxia-telangiectasia,” Medical and Pediatric Oncology, vol. 31, no. 6, pp. 491–497, 1998.
Copyright © 2009 M. I. Spasova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.